Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
KROS
LYEL
Add up to 3 more stocks
KROS
Keros Therapeutics, Inc.
-3.04%
$11.17-0.35Delayed quote: Oct 6, 2026, 3:05 PM EDT
Market Cap
$221.47M
52W Range
$9.69 - $22.55
LYEL
Lyell Immunopharma, Inc.
-3.97%
$8.71-0.36Delayed quote: Oct 6, 2026, 3:05 PM EDT
Market Cap
$213.43M
52W Range
$8.66 - $45.00
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.84 | 0.91 |
| P/S Ratio | 14.75 | 7904.92 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 94.7% | -31952.8% |
| Operating Margin | 28.9% | -566038.9% |
| Net Margin | -553.9% | -920285.2% |
| ROE | -31.7% | -106.3% |
| ROA | -28.9% | -79.9% |
| ROIC | -36.5% | -70.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 21.96 | 5.36 |
| Quick Ratio | 21.96 | 5.36 |
| Debt/Equity | 0.06 | 0.16 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.